Concepedia

Zhouyang Tian

ZT

Statistics

Publications

6

Citations

270

H-Index

6

Active since

1987

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Zhouyang Tian is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and epigenetics.

ORCID

Publications per year

1987–2025

6

Publications

6

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells

Wei Song, Y-T Tai, Zhouyang Tian et al. · Leukemia · 2010 · 97 citations · Full text

, , +9

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells

Deepika Sharma Das, Arghya Ray, Abhishek Das et al. · Leukemia · 2016 · 84 citations · Full text

, , +14

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib

Arghya Ray, Zhouyang Tian, Deepika Sharma Das et al. · Leukemia · 2014 · 48 citations · Full text

, , +13

High-efficiency Pb2+ removal by hydroxy-sodalite for point-of-use drinking water purification

Qian Zheng, Ziwei Wang, Zhouyang Tian et al. · Journal of Hazardous Materials · 2025 · 17 citations

, , +10

Quinones from Ardisia cornudentata

Zhouyang Tian, Ming‐Wen Chang, M. Sandrino et al. · Phytochemistry · 1987 · 14 citations

, , +4

1–5 of 6